Atria Wealth Solutions Inc. Has $3.66 Million Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Key Points

• Atria Wealth Solutions Inc. reduced its stake in Intuitive Surgical, Inc. by 16.8%, owning 7,394 shares valued at approximately $3.66 million after selling 1,497 shares.
• Institutional investors own 83.64% of Intuitive Surgical's stock, with several large firms increasing their holdings, including GAMMA Investing LLC, which boosted its position by over 54,010.7%.
• Analysts currently rate Intuitive Surgical as a "Moderate Buy" with a consensus price target of $595.95, despite varying target adjustments from firms like Deutsche Bank and Barclays.

Atria Wealth Solutions Inc. trimmed its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 16.8% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 7,394 shares of the medical equipment provider's stock after selling 1,497 shares during the period. Atria Wealth Solutions Inc.'s holdings in Intuitive Surgical were worth $3,662,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of the stock. Northern Trust Corp lifted its position in shares of Intuitive Surgical by 15.8% during the fourth quarter. Northern Trust Corp now owns 3,619,293 shares of the medical equipment provider's stock worth $1,889,126,000 after purchasing an additional 494,496 shares in the last quarter. Capital Research Global Investors lifted its position in shares of Intuitive Surgical by 25.5% during the fourth quarter. Capital Research Global Investors now owns 3,381,302 shares of the medical equipment provider's stock worth $1,764,904,000 after purchasing an additional 687,906 shares in the last quarter. GAMMA Investing LLC lifted its position in shares of Intuitive Surgical by 54,010.7% during the first quarter. GAMMA Investing LLC now owns 3,028,576 shares of the medical equipment provider's stock worth $14,999,630,000 after purchasing an additional 3,022,979 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in shares of Intuitive Surgical by 12.8% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,826,972 shares of the medical equipment provider's stock worth $1,475,566,000 after purchasing an additional 319,694 shares in the last quarter. Finally, Brown Advisory Inc. lifted its position in shares of Intuitive Surgical by 5.8% during the fourth quarter. Brown Advisory Inc. now owns 1,746,131 shares of the medical equipment provider's stock worth $911,411,000 after purchasing an additional 95,249 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on the stock. Deutsche Bank Aktiengesellschaft lowered shares of Intuitive Surgical from a "hold" rating to a "sell" rating and reduced their target price for the stock from $515.00 to $440.00 in a research report on Monday, June 9th. Barclays cut their price objective on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a report on Thursday, April 24th. Evercore ISI increased their price objective on shares of Intuitive Surgical from $470.00 to $550.00 and gave the company an "in-line" rating in a report on Tuesday, July 8th. Piper Sandler restated an "overweight" rating and issued a $595.00 price objective (up from $575.00) on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Finally, Erste Group Bank restated a "hold" rating on shares of Intuitive Surgical in a report on Wednesday, July 23rd. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have given a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $595.95.

Insider Transactions at Intuitive Surgical

In other news, SVP Mark Brosius sold 216 shares of the stock in a transaction on Friday, June 6th. The shares were sold at an average price of $563.11, for a total transaction of $121,631.76. Following the completion of the sale, the senior vice president owned 907 shares of the company's stock, valued at $510,740.77. This represents a 19.23% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Myriam Curet sold 4,500 shares of the stock in a transaction on Friday, July 25th. The stock was sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the sale, the executive vice president directly owned 353 shares of the company's stock, valued at $173,845.44. This represents a 92.73% decrease in their position. The disclosure for this sale can be found here. Insiders sold 15,903 shares of company stock valued at $7,932,778 over the last quarter. Corporate insiders own 0.70% of the company's stock.

Intuitive Surgical Stock Down 0.9%

Shares of ISRG stock opened at $469.81 on Friday. The firm has a fifty day moving average of $518.14 and a 200-day moving average of $530.28. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00. The company has a market capitalization of $168.42 billion, a price-to-earnings ratio of 65.52, a P/E/G ratio of 4.97 and a beta of 1.59.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The company had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. During the same quarter in the prior year, the firm earned $1.78 earnings per share. The firm's revenue was up 21.4% compared to the same quarter last year. On average, equities analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.